Endocrine Feedback Loop Titelbild

Endocrine Feedback Loop

Endocrine Feedback Loop

Von: Endocrine Society
Jetzt kostenlos hören, ohne Abo

Das größte Angebot der Saison | 0,99 € pro Monat für die ersten 3 Monate + 15 € Audible-Guthaben

Danach 6,99 €/Monat. Bedingungen gelten. Monatlich kündbar.
Über diesen Titel
Endocrine Feedback Loop is a monthly journal club podcast series brought to you by the Endocrine Society. Hosted by endocrinologist Chase Hendrickson, MD, from Vanderbilt University, each episode features an expert educator and a topical specialist dissecting recently published journal articles and discussing implications for clinical practice.Endocrine Society. Copyright 2026 Hygiene & gesundes Leben
  • EFL079 - Incidental Physical Activity and the Risk for Type 2 Diabetes
    Nov 19 2026

    How should we think about incidental physical activity in lowering the risk of type 2 diabetes? Hear more in this episode!

    For our 79th episode, we review a recent Journal of Clinical Endocrinology & Metabolism (JCEM) article on incidental physical activity, the everyday movement outside of structured exercise. Many patients now track this activity with wearable devices, and clinicians often aren't sure what to do with that data. The study used wrist accelerometer data from nearly 23,000 UK adults who reported that they don't exercise. It found that just a few minutes a day of vigorous incidental activity was linked to a lower risk of type 2 diabetes. The findings also question the guideline assumption that 1 minute of vigorous activity equals 2 minutes of moderate activity.

    Host Chase Hendrickson, MD, MPH, MHCC, from Vanderbilt University talks with regular contributor Diana Soliman, MD, from the University of Miami, and guest expert Jane Reusch, MD, from the University of Colorado. They discuss a study by Sabag et al., published online in September 2026 in JCEM titled, "The dose-response association between wearables-quantified incidental physical activity and type 2 diabetes: a prospective cohort study."

    Read the article: https://doi.org/10.1210/clinem/dgag316

    Mehr anzeigen Weniger anzeigen
    35 Min.
  • EFL078 - SGLT1 Inhibition for the Treatment of Post-Bariatric Hypoglycemia
    Oct 22 2026

    For our 78th episode, we review a recent Journal of the Endocrine Society (JES) article reporting results from a Phase 2, single-dose trial of an SGLT1 inhibitor for post-bariatric hypoglycemia. This condition can be particularly difficult to diagnose and manage, and current treatments are not uniformly effective or well tolerated, with no FDA-approved therapy currently available. The study explores whether targeting intestinal glucose absorption could offer a new oral treatment option, while raising important questions about patient selection, clinically meaningful outcomes, and what a larger Phase 3 trial will need to demonstrate. Host Chase Hendrickson, MD, MPH, MHCC, from Vanderbilt University talks with regular contributor Steven D. Wittlin, MD, from the University of Rochester Medical Center, and guest expert Sangeeta Kashyap from Weill Cornell Health. They discuss a study by Lawler et al., published in the August 2026 issue of JES titled, “A single dose trial of mizagliflozin for the treatment of postbariatric hypoglycemia.”

    Mehr anzeigen Weniger anzeigen
    35 Min.
  • EFL077 - Inflammation vs. Immune-System Dysfunction in PCOS
    Sep 18 2026

    For our 77th episode, we discuss a study in the Journal of Clinical Endocrinology & Metabolism investigating the role of immune signaling in polycystic ovary syndrome (PCOS), now renamed polyendocrine metabolic ovarian syndrome (PMOS). Using a multiracial case-control design, the authors examined whether PCOS is characterized by chronic inflammation or whether immune dysregulation plays a more central role in its pathophysiology.

    Host Chase Hendrickson, MD, MPH, MHCC, from Vanderbilt Health, is joined by regular contributor Anna Goldman, MD, from Harvard Medical School, Brigham and Women's Hospital, and Atrius Health, along with guest expert Corrine Welt, MD, Chief of Endocrinology at the University of Utah, to discuss "Multiracial Cytokine Profiling Reveals Immune Dysregulation not Chronic Inflammation in Polycystic Ovary Syndrome." Together, they explore the implications of the syndrome's recent name change, review the study's unexpected findings of lower circulating inflammatory markers in women with PCOS, and discuss the challenges of disentangling the effects of adiposity, metabolism, and immune function. The conversation highlights what these results reveal about the evolving understanding of PCOS and whether they have implications for current clinical practice.

    Mehr anzeigen Weniger anzeigen
    28 Min.
adbl_web_anon_alc_button_suppression_t1
Noch keine Rezensionen vorhanden